Trial NCT02720120

View at ClinicalTrials.gov 
Org. Study IDs: WA18230
Secondary IDs: 2004-002132-26

Last trial update was posted on 2016-03-28

MeSH Interventions

Ocrelizumab

MeSH Conditions

Arthritis Arthritis, Rheumatoid

Other Conditions

Rheumatoid Arthritis

Stopping Reasons

The overall benefit risk profile of ocrelizumab was not favorable in RA

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID